Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemia
Authors:
- 1 June 2019
- journal article
- letter
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 25 (6) , 771-773
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid CancerClinical Infectious Diseases, 2018
- Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphomaHematological Oncology, 2017
- Screening of the central nervous system in children with invasive pulmonary aspergillosisMedical Mycology Case Reports, 2014